Powered by 20 A electrical current, M-110P Microfluidizer laboratory scale processor requires no compressed air or cooling water. Operating pressures from 2,000-30,000 psi enable production of nano-suspensions and nano-emulsions as well as liposomal encapsulation and cell disruption.
Designing and producing food by shaping molecules and atoms is the future of the food industry worldwide. 600 Companies worldwide in Research , Development and Production using nanotechnologies and molecular science in food processing and packaging.
Nanoscience Inc., the specialist niche investor in emerging technologies with strong commercial propositions from within the growing nanotechnology sector, is pleased to announce that its wholly owned subsidiary, Toumaz Technology Limited has been granted its core patent surrounding the AMx (Advanced Mixed Signal) technology in the key jurisdiction of Australia.
Copernicus Therapeutics, Inc. announced today that it received a milestone payment from Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), a non-profit affiliate of the Cystic Fibrosis Foundation. This milestone payment is part of a research, development, and commercialization agreement between CFFT and Copernicus to develop gene therapy to treat cystic fibrosis.
Universal Capital Management, Inc., a publicly traded venture capital company that provides emerging growth companies with management and strategic resources for successful growth, acknowledged the Form 8-K filed by Third-Order Nanotechnologies, Inc. on December 7, 2007, one of Universal Capital's largest portfolio companies.